» Articles » PMID: 38573841

Surveillance To Track Progress Toward Polio Eradication - Worldwide, 2022-2023

Abstract

The reliable and timely detection of poliovirus cases through surveillance for acute flaccid paralysis (AFP), supplemented by environmental surveillance of sewage samples, is a critical component of the polio eradication program. Since 1988, the number of polio cases caused by wild poliovirus (WPV) has declined by >99.9%, and eradication of WPV serotypes 2 and 3 has been certified; only serotype 1 (WPV1) continues to circulate, and transmission remains endemic in Afghanistan and Pakistan. This surveillance update evaluated indicators from AFP surveillance, environmental surveillance for polioviruses, and Global Polio Laboratory Network performance data provided by 28 priority countries for the program during 2022-2023. No WPV1 cases have been detected outside of Afghanistan and Pakistan since August 2022, when an importation into Malawi and Mozambique resulted in an outbreak during 2021-2022. During 2022-2023, among 28 priority countries, 20 (71.4%) met national AFP surveillance indicator targets, and the number of environmental surveillance sites increased. However, low national rates of reported AFP cases in priority countries in 2023 might have resulted from surveillance reporting lags; substantial national and subnational AFP surveillance gaps persist. Maintaining high-quality surveillance is critical to achieving the goal of global polio eradication. Monitoring surveillance indicators is important to identifying gaps and guiding surveillance-strengthening activities, particularly in countries at high risk for poliovirus circulation.

Citing Articles

Characterization of environmental and clinical surveillance inputs to support prospective integrated modeling of the polio endgame.

Badizadegan K, Thompson K PLOS Glob Public Health. 2025; 5(2):e0004168.

PMID: 39919149 PMC: 11805368. DOI: 10.1371/journal.pgph.0004168.


Tracking acute flaccid paralysis in Niger: a half-decade epidemiological portrait (2016-2021).

Ishagh E, Ouedraogo M, Oumarou B, Kaya M, Diawara G, Camara A BMC Infect Dis. 2025; 25(1):79.

PMID: 39825249 PMC: 11742228. DOI: 10.1186/s12879-025-10457-w.


Monitoring the Risk of Type-2 Circulating Vaccine-Derived Poliovirus Emergence During Roll-Out of Type-2 Novel Oral Polio Vaccine.

Peak C, Lyons H, Voorman A, Gray E, Cooper L, Blake I Vaccines (Basel). 2025; 12(12.

PMID: 39771970 PMC: 11680014. DOI: 10.3390/vaccines12121308.


Advancing poliovirus eradication: lessons learned from piloting direct molecular detection of polioviruses in high-risk and priority geographies.

Marcet P, Short B, Deas A, Sun H, Harrington C, Shaukat S Microbiol Spectr. 2024; 13(2):e0227924.

PMID: 39665559 PMC: 11792523. DOI: 10.1128/spectrum.02279-24.


Antiviral Development for the Polio Endgame: Current Progress and Future Directions.

Xie H, Rhoden E, Liu H, Ogunsemowo F, Mainou B, Burke R Pathogens. 2024; 13(11).

PMID: 39599522 PMC: 11597170. DOI: 10.3390/pathogens13110969.


References
1.
Stehling-Ariza T, Wilkinson A, Diop O, Jorba J, Asghar H, Avagnan T . Surveillance To Track Progress Toward Poliomyelitis Eradication - Worldwide, 2021-2022. MMWR Morb Mortal Wkly Rep. 2023; 72(23):613-620. PMC: 10328463. DOI: 10.15585/mmwr.mm7223a1. View

2.
Lee S, Greene S, Burns C, Tallis G, Wassilak S, Bolu O . Progress Toward Poliomyelitis Eradication - Worldwide, January 2021-March 2023. MMWR Morb Mortal Wkly Rep. 2023; 72(19):517-522. PMC: 10208367. DOI: 10.15585/mmwr.mm7219a3. View

3.
Bjork A, Akbar I, Chaudhury S, Wadood M, Ather F, Jorba J . Progress Toward Poliomyelitis Eradication - Afghanistan, January 2022-June 2023. MMWR Morb Mortal Wkly Rep. 2023; 72(38):1020-1026. PMC: 10519716. DOI: 10.15585/mmwr.mm7238a1. View

4.
Diop O, Kew O, de Gourville E, Pallansch M . The Global Polio Laboratory Network as a Platform for the Viral Vaccine-Preventable and Emerging Diseases Laboratory Networks. J Infect Dis. 2017; 216(suppl_1):S299-S307. PMC: 5853949. DOI: 10.1093/infdis/jix092. View

5.
Bigouette J, Henderson E, Traore M, Wassilak S, Jorba J, Mahoney F . Update on Vaccine-Derived Poliovirus Outbreaks - Worldwide, January 2021-December 2022. MMWR Morb Mortal Wkly Rep. 2023; 72(14):366-371. PMC: 10078846. DOI: 10.15585/mmwr.mm7214a3. View